Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Hempdocon Jun 09, 2020 1:13am
568 Views
Post# 31127374

Not Worried About SP...

Not Worried About SP...

Honestly, if everyone believes in the science, then this pps is a gift.  I'm certainly not one of those highly experienced/technical traders like some of you, but it seems to me the greatest opportunity for maximal wealth creation is if this company can survive independently for as LONG as possible. You can ultimately fully own/license your technology, etc....but a premature buyout or partnership simply reduces prematurely your maximum future reward imo.

People may scoff at the idea of future financing &/or a share consolidation & their dilutive impacts, but I certainly wouldn't scoff at the above if done properly...I guess that's a big IF in many investors' minds.  But if we were to stay independent, I'd be interested in hearing some of your thoughts about the possibility of a rights offering (non-transferable) for future financing of a second indication?  I believe if we can stay independent & prove our superior efficacy in a second or "hard-to-reach" indication, our value "takes off" as we are now seen as a true threat in the solid tumor market (deep or superficial/luminal).

Obviously, I'm not sure mgmt would even offer such a gesture of consideration to its shareholder base...they should.  Such an offering would certainly offset any dilutive impact of a future share consolidation, if needed. IMO, if we can get FDA approved for NMIBC, we may not immediately qualify for an NAS listing, but ultimately, I don't think it would require more than a 1-for-2 consolidation, during which time you have protected your wealth & likely created an opportunity for A LOT more vs selling out prematurely.  Call me an optimist or maybe just a dreamer.  
 



 

Bullboard Posts